Mount Sinai Beth Israel Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2018
NCT03462927
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Department of Dermatology, Mount Sinai Beth Israel | Mount Sinai Beth Israel